Gallium Ga 68 Gozetotide

CHEMBL5095039 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
1011.9 g/mol
LogP
Phase
4

This radioactive diagnostic agent is used in PET imaging to detect prostate cancer that has spread or recurred. It binds to prostate-specific membrane antigen (PSMA), a protein highly expressed on prostate cancer cells, allowing the imaging device to locate even small deposits of cancer. It is particularly useful when conventional imaging may not detect disease recurrence.

น้ำหนักโมเลกุล

1011.9000 g/mol

TPSA

381.00 Ų

ด้านการรักษา

กลไกการออกฤทธิ์

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CN(CCN(CC(=O)[O-])Cc1cc(CCC(=O)NCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc1[O-])Cc1cc(CCC(=O)O)ccc1[O-].[68Ga+3].[OH3+]

InChI

InChI=1S/C44H62N6O17.Ga.H2O/c51-34-13-8-28(22-30(34)24-49(26-40(59)60)20-21-50(27-41(61)62)25-31-23-29(9-14-35(31)52)11-16-38(55)56)10-15-37(54)46-18-4-1-2-7-36(53)45-19-5-3-6-32(42(63)64)47-44(67)48-33(43(65)66)12-17-39(57)58;;/h8-9,13-14,22-23,32-33,51-52H,1-7,10-12,15-21,24-27H2,(H,45,53)(H,46,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H2,47,48,67);;1H2/q;+3;/p-3/t32-,33-;;/m0../s1/i;1-2;

Molecular Formula

C44H59GaN6O17

HBD / HBA

9 / 19

พันธะที่หมุนได้

33

อะตอมหนัก

68

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This radioactive diagnostic agent is used in PET imaging to detect prostate cancer that has spread or recurred. It binds to prostate-specific membrane antigen (PSMA), a protein highly expressed on prostate cancer cells, allowing the imaging device to locate even small deposits of cancer. It is particularly useful when conventional imaging may not detect disease recurrence.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Gallium Ga 68 Gozetotide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5095039. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 154572876. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.